rfhg_61203.1

Basic information about the TSS

---

TSS ID: rfhg_61203.1 TSS ID(Version3): hg_49218.1 hg_49221.1 hg_49220.1 hg_49219.1 hg_49217.1 Species: human Chr: chr4		Start: 108620529 End: 108620645 Strand: +
Source datasets	FANTOM5|DRA000914|PRJNA4843412|DRA013844|PRJNA615891 |PRJNA401781|PRJNA548673|PRJNA597322|PRJDB5282
Protocol	CAGE|NETCAGE|SLIC_CAGE|oligo_capping|RAMPAGE|ReCappable-seq |TIF-seq2|STRIPE-seq|C1CAGE
TSS cluster detected*	13

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3613026,EH38E2319039)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000502534.5:0 ENST00000394667.8:0 ENST00000394665.5:0 ENST00000503574.1:0 ENST00000506397.5:0 NM_001319236.2:0 NM_001319235.2:0 NM_001319232.2:0 NM_000995.5:0 NM_033625.4:0 NM_001319234.1:0 BC106009:0 LF383833:0 MA619410:0 D28420:0 BC070208:0 AK055920:0 GeneID: 6164 HGNC/MGI_ID: HGNC:10340 UniProt_ID: A1LUY1 Nearer transcript ids and distances: ENST00000394668.2:11 BC001773:11 view more...

Gene_name: RPL34 Gene_symbol: RPL34 Gene_synonyms: L34 Gene_source: HGNC:10340

TATA-Box annotation

---

Distance to TSS:	-3
Nearest PromoterID:	NM_033625
Entrez ID:	6164
Nearest Unigene:	Hs.438227
Nearest Refseq:	NM_000995
Nearest Ensembl:	ENSG00000109475
Gene Name:	RPL34
Gene Alias:	L34
Gene Type:	protein-coding
CpG%:	0.025862
GC%:	0.435897
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPL34 p2@RPL34 p3@RPL34 p4@RPL34 p5@RPL34
Sample		p1@RPL34	p2@RPL34	p3@RPL34	p4@RPL34	p5@RPL34
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	43.25	22.01	37.60	9.93	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	33.79	18.01	35.00	8.30	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	35.30	21.03	34.53	8.29	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	31.60	20.79	36.38	8.52	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	40.49	20.92	38.02	9.45	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	31.20	16.67	43.22	11.82	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	29.41	30.07	61.88	20.48	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	40.69	20.10	42.63	15.74	2.42
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	42.96	25.43	48.09	12.82	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	20.29	15.07	37.10	5.22	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	14.55	13.74	27.08	3.64	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	19.92	16.67	29.27	3.66	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	39.17	15.47	4.51	0.48	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	25.56	13.53	6.31	0.15	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	47.64	18.88	7.90	1.10	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	34.20	13.83	7.29	0.75	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	26.43	15.94	6.33	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	22.78	15.19	8.86	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	22.39	15.99	5.86	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	48.89	19.86	8.12	0.30	1.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	30.47	17.11	9.09	0.27	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	42.47	23.13	6.39	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.70	16.54	6.98	0.52	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	32.52	16.02	9.22	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	25.54	19.09	7.74	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	47.79	25.64	9.81	1.27	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	32.97	21.43	9.34	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	42.91	24.28	6.13	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	44.90	20.03	9.21	0.32	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	37.64	20.45	8.14	0.36	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	39.98	20.31	10.26	1.05	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	45.33	24.23	8.79	1.37	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	30.18	21.10	9.50	0.42	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	42.88	33.15	16.49	0.82	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	39.45	23.00	8.23	0.19	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	34.49	17.05	8.05	0.77	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	42.31	20.85	9.20	1.64	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	42.31	19.14	7.05	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	51.86	28.36	11.34	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	48.25	28.57	10.56	1.92	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	32.23	21.17	6.35	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	33.82	23.28	7.91	0.73	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	37.54	22.99	8.65	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	38.11	18.18	8.04	0.87	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	50.80	24.90	9.64	1.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	61.65	27.22	11.63	0.23	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	37.19	22.55	8.88	0.72	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	72.43	29.21	14.31	1.79	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	38.30	24.66	7.66	0.24	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	36.60	27.30	11.93	1.01	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	40.79	24.39	8.40	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	41.36	26.68	7.12	0.00	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	321.82	27.98	41.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	35.13	23.42	9.94	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	32.14	23.53	7.95	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	107.38	57.89	38.59	2.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	92.77	28.01	16.99	0.92	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	31.44	29.82	8.75	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	28.26	26.66	6.74	0.64	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	63.81	28.60	16.35	1.26	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	41.60	26.09	10.58	1.41	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	38.13	24.11	6.73	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	88.37	21.50	19.90	2.39	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	54.02	30.58	16.65	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	24.37	24.37	5.85	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	29.11	21.30	6.74	0.71	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	32.33	129.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	86.87	31.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	39.49	29.74	5.36	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	35.21	35.70	7.44	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	23.46	29.09	4.69	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	33.78	30.14	6.29	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	25.68	27.53	5.57	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	20.79	25.38	3.97	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	22.65	24.55	9.19	2.38	1.90
Adipocyte - breast, donor2	11327-117E4	22.78	12.99	7.06	1.28	0.16
Adipocyte - omental, donor1	11473-119C6	16.16	21.88	8.65	1.53	0.25
Adipocyte - omental, donor2	11474-119C7	55.31	22.42	8.97	2.99	0.75
Adipocyte - omental, donor3	11475-119C8	67.32	15.41	5.69	2.01	1.00
Adipocyte - perirenal, donor1	11476-119C9	59.33	25.52	16.59	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	19.79	2.20	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	46.97	32.07	7.68	2.26	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	45.18	7.65	3.82	0.17	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	46.35	21.71	8.41	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	29.34	21.62	6.43	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	30.39	17.56	6.97	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	26.45	16.46	7.64	1.18	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	22.52	15.44	3.30	1.13	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	34.86	16.78	3.87	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	33.06	11.20	5.33	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	22.81	10.57	3.90	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	29.11	9.15	1.66	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	22.60	13.31	2.51	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	25.53	11.13	1.31	0.33	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	14.01	6.09	1.22	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	55.69	56.13	33.15	15.47	4.20
Alveolar Epithelial Cells, donor2	11590-120G6	73.15	34.07	21.87	7.53	4.30
Alveolar Epithelial Cells, donor3	11671-122G6	27.55	16.77	4.79	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	48.39	28.25	16.55	1.62	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	35.14	16.73	6.69	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	39.86	26.71	15.20	1.23	0.62
Anulus Pulposus Cell, donor1	11248-116E6	34.56	16.02	12.36	1.03	1.60
Anulus Pulposus Cell, donor2	11463-119B5	45.31	11.76	8.82	1.47	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	101.09	22.91	20.67	2.25	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	86.39	24.31	23.88	4.34	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	44.95	44.95	27.82	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	90.27	22.72	20.03	1.49	2.39
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	128.99	30.35	22.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	33.66	32.34	20.46	2.64	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	73.42	19.17	21.44	2.92	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	86.89	30.10	16.50	1.46	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	38.01	30.88	20.79	2.97	2.97
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	99.43	22.22	21.84	1.13	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	87.81	29.75	14.51	2.90	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	27.58	23.82	20.06	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	26.36	26.52	16.80	2.14	1.81
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	64.15	16.38	23.20	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	56.40	40.71	22.77	4.52	3.02
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	84.65	25.18	20.90	1.61	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	49.31	27.77	16.82	3.59	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	23.79	30.47	17.91	2.94	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	81.94	16.58	18.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	55.89	24.88	17.91	1.82	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	33.62	27.62	25.22	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	10.62	24.78	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	43.23	25.04	14.58	2.92	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	37.75	50.34	20.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	109.71	29.13	25.24	1.94	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	77.41	28.08	14.80	3.79	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	39.98	26.65	18.17	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	124.27	24.51	19.95	1.71	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	51.95	21.38	16.46	1.71	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	26.84	27.36	18.07	3.10	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	80.70	26.74	20.18	2.35	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	46.95	22.51	14.15	2.25	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	30.68	36.39	17.84	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	84.23	23.98	16.38	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	46.37	26.80	11.44	2.41	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	29.70	29.70	15.44	2.38	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	142.91	24.41	24.41	2.03	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	50.17	31.07	21.14	3.57	2.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	29.23	33.04	15.88	2.54	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	85.44	26.76	15.10	2.59	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	57.79	26.04	19.69	2.12	1.69
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	28.13	26.68	16.82	3.48	2.61
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	76.52	27.40	19.84	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	54.08	23.06	14.41	3.05	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	34.75	30.11	23.16	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	46.48	10.56	10.56	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	62.18	20.37	18.87	0.86	2.57
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	34.29	30.08	16.24	0.60	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	134.13	26.24	25.51	2.19	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	68.73	25.98	18.85	2.53	1.84
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	17.85	15.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	62.29	44.24	30.76	5.08	3.05
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	49.75	27.04	17.96	3.72	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	25.70	33.97	15.91	2.45	2.14
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	101.82	29.16	26.29	4.30	4.30
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	48.78	26.39	11.31	1.77	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	19.84	42.72	21.36	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	88.07	32.68	21.60	1.11	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	50.84	23.83	14.56	1.85	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	31.26	31.26	19.99	2.18	0.36
Astrocyte - cerebellum, donor1	11500-119F6	49.37	43.72	24.32	3.93	2.09
Astrocyte - cerebellum, donor2	11580-120F5	48.10	26.36	16.60	1.88	1.03
Astrocyte - cerebellum, donor3	11661-122F5	43.21	21.18	13.84	0.63	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	40.78	29.28	21.26	0.70	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	27.99	49.34	31.22	5.82	1.29
Astrocyte - cerebral cortex, donor3	11392-118C6	30.43	30.88	11.63	2.09	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	47.37	18.69	12.73	7.34	2.29
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	49.11	27.06	19.67	9.02	3.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	36.41	21.28	16.05	10.24	4.89
Basophils, donor1	12241-129G9	67.21	6.02	2.09	1.31	1.31
Basophils, donor2	12242-129H1	77.93	8.30	0.36	1.80	0.36
Basophils, donor3	12243-129H2	75.85	4.12	1.62	1.76	1.18
Bronchial Epithelial Cell, donor1	11511-119G8	68.35	23.93	8.41	4.31	2.16
Bronchial Epithelial Cell, donor2	11591-120G7	30.63	14.63	2.29	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	7.17	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	71.55	37.03	31.38	21.34	5.02
Bronchial Epithelial Cell, donor5	11457-119A8	14.56	11.44	6.03	2.70	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	15.20	4.61	5.30	1.61	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	76.30	30.05	10.08	4.86	2.16
Burkitt's lymphoma cell line:DAUDI	10422-106C8	64.82	55.75	53.90	3.92	2.78
Burkitt's lymphoma cell line:RAJI	10476-106I8	85.48	50.31	36.57	13.74	7.69
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	192.18	30.70	54.68	3.20	3.20
CD133+ stem cells - cord blood derived, pool1	12223-129E9	175.81	31.03	62.05	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	50.72	7.33	0.56	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	44.54	3.53	0.74	0.93	0.37
CD14+ Monocytes, donor3	11381-118B4	47.20	3.07	0.22	0.00	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	31.70	10.47	0.85	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	28.43	7.20	0.76	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	22.03	7.56	0.99	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	47.99	5.20	1.73	0.14	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	53.71	5.43	0.60	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	52.59	4.03	1.18	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	38.50	4.52	1.34	0.00	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	45.54	3.86	2.21	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	59.01	5.95	2.98	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	35.05	3.33	1.17	0.00	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	47.72	4.10	2.31	0.18	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	77.91	7.83	3.05	0.87	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	41.91	2.11	2.11	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	76.56	3.17	4.22	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	107.61	4.44	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	42.24	3.57	2.23	0.30	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	60.66	3.79	3.99	0.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	110.97	9.58	4.37	0.42	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	59.03	3.43	2.06	0.46	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	62.21	5.66	1.36	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	59.80	2.18	1.75	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	37.12	4.57	2.15	0.00	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	54.61	3.66	2.27	0.17	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	64.81	5.89	1.26	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	37.11	2.20	1.29	0.55	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	57.42	4.58	0.35	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	69.32	5.70	2.19	0.88	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	35.40	3.84	2.44	0.35	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	60.58	1.12	4.83	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	87.30	8.62	2.37	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	31.94	6.14	1.23	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	71.39	3.48	2.55	0.23	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	77.02	6.96	3.48	0.46	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	95.90	15.04	2.83	1.53	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	94.25	15.48	1.62	0.92	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	115.24	15.60	3.47	0.43	1.52
CD14+CD16- Monocytes, donor1	11788-124B6	60.11	10.59	1.40	1.09	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	85.58	6.81	3.14	0.35	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	74.25	7.80	1.11	0.67	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	104.88	27.81	2.04	0.77	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	105.61	14.27	1.32	0.44	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	104.43	18.32	2.53	0.63	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	174.78	22.36	4.06	0.00	6.10
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	200.00	23.73	9.49	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	204.01	16.57	9.32	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	237.73	25.05	6.40	1.60	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	238.01	24.12	8.04	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	219.71	25.27	11.93	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	195.30	22.75	7.06	0.00	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	287.39	31.64	15.82	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	198.08	5.75	3.29	0.82	1.64
CD19+ B Cells, donor2	11624-122B4	183.53	7.25	2.90	0.73	1.45
CD19+ B Cells, donor3	11705-123B4	183.25	5.05	3.53	1.01	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	58.59	41.62	11.72	5.25	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	66.71	33.56	16.78	4.39	3.20
CD34+ Progenitors, donor1	11545-120B6	177.72	13.05	24.10	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	178.09	9.55	20.79	1.69	3.37
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	208.54	24.42	33.82	6.01	2.63
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	196.85	30.67	50.73	4.74	2.48
CD4+ T Cells, donor1	11225-116C1	193.17	7.86	3.21	1.79	1.79
CD4+ T Cells, donor2	11306-117C1	163.50	4.90	3.67	1.22	2.45
CD4+ T Cells, donor3	11382-118B5	147.62	7.93	3.05	0.91	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	174.07	13.78	4.34	1.02	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	119.04	16.62	3.59	1.35	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	98.31	13.51	2.30	0.57	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	403.93	20.39	3.32	0.95	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	627.88	13.34	7.02	1.40	6.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	487.84	9.89	0.00	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	90.32	12.72	2.89	0.43	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	60.16	11.02	4.58	0.34	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	52.23	12.57	3.22	0.32	1.77
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	249.70	18.38	2.24	0.90	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	291.39	16.07	2.10	1.05	2.80
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	238.47	10.12	1.76	0.44	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	158.96	9.70	1.26	1.26	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	62.75	13.92	3.53	1.66	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	83.20	15.70	3.34	2.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	252.63	17.13	2.45	1.36	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	469.49	17.69	2.68	0.00	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	451.89	5.38	1.79	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	105.69	14.83	5.38	0.74	1.85
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	82.10	12.13	3.03	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	79.44	11.77	2.94	0.21	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	335.22	23.76	8.60	0.51	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	324.94	22.96	6.07	0.87	3.47
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	295.05	15.25	1.74	0.87	3.05
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	240.51	21.77	3.96	1.48	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	320.35	27.70	6.46	0.92	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	311.27	34.90	6.98	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	340.07	18.28	3.88	0.00	2.49
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	371.77	24.78	4.42	0.74	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	183.26	23.10	3.08	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	206.99	18.26	2.86	0.36	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	252.07	37.39	2.77	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	142.09	10.48	2.95	0.33	1.64
CD8+ T Cells, donor2	11307-117C2	106.62	8.26	3.38	0.75	1.13
CD8+ T Cells, donor3	11383-118B6	149.22	8.58	1.77	1.26	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	42.67	10.55	5.96	6.42	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	31.15	9.11	4.55	5.03	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	27.36	12.31	9.03	6.29	2.74
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	79.26	17.71	11.11	5.10	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	33.84	8.88	5.76	3.12	2.16
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	37.97	11.60	7.96	5.46	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	45.41	13.69	8.26	9.13	1.74
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	39.22	16.58	11.05	12.90	2.63
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	34.47	18.29	9.15	13.37	2.11
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	44.07	14.19	10.57	8.45	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.89	18.01	11.62	6.10	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	43.43	9.59	11.99	3.20	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	21.45	6.13	4.38	1.75	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	27.78	2.73	5.92	3.19	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	15.66	4.48	7.46	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	54.38	7.92	6.84	6.48	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	38.84	8.06	5.18	3.16	2.01
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	29.23	13.67	5.19	5.42	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	55.78	10.77	10.14	10.46	2.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	39.37	11.69	7.38	8.61	3.38
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	49.05	10.90	6.73	6.73	1.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	31.36	11.47	10.33	3.82	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	23.25	11.43	11.03	7.49	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	29.50	12.86	12.10	9.83	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	18.47	8.03	8.83	0.80	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	20.98	4.90	4.20	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	41.07	2.00	5.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	12.79	10.97	1.83	3.66	1.83
Cardiac Myocyte, donor2	11605-120I3	59.29	23.22	18.28	0.99	1.48
Cardiac Myocyte, donor3	11686-122I3	66.30	35.88	14.42	1.16	1.05
Chondrocyte - de diff, donor1	11261-116G1	70.03	28.77	16.99	1.04	2.43
Chondrocyte - de diff, donor2	11338-117F6	52.60	15.99	8.88	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	28.79	12.06	10.24	1.02	1.02
Chondrocyte - re diff, donor2	11339-117F7	35.81	20.59	8.95	2.69	1.79
Chondrocyte - re diff, donor3	11411-118E7	34.78	10.51	4.85	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	38.67	42.92	24.21	3.56	2.07
Ciliary Epithelial Cells, donor2	11323-117D9	42.11	38.26	28.22	4.28	3.42
Ciliary Epithelial Cells, donor3	11399-118D4	30.97	31.59	17.61	2.30	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	15.59	11.10	0.92	1.10	0.18
Corneal Epithelial Cells, donor1	11526-119I5	44.35	25.25	9.22	4.39	0.22
Corneal Epithelial Cells, donor2	11606-120I4	21.61	22.75	13.65	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	42.95	35.28	14.06	11.25	2.56
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	13.54	8.75	1.49	1.16	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	17.66	9.46	3.15	0.63	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	3.45	10.35	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.28	6.26	1.84	0.54	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	93.27	3.42	3.07	1.37	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	111.64	11.75	3.92	1.31	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	150.51	3.87	3.87	3.39	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	17.18	25.52	18.84	3.00	1.83
Endothelial Cells - Aortic, donor1	11263-116G3	42.83	20.54	12.32	3.52	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	48.64	27.15	21.21	1.41	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	13.37	19.27	14.15	3.15	0.39
Endothelial Cells - Artery, donor1	11264-116G4	42.76	12.51	12.51	1.75	1.16
Endothelial Cells - Artery, donor2	11341-117F9	14.82	4.47	4.71	0.94	0.47
Endothelial Cells - Artery, donor3	11413-118E9	27.35	23.32	16.13	2.98	1.75
Endothelial Cells - Lymphatic, donor1	11236-116D3	31.03	34.80	16.40	2.22	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	26.78	21.91	11.87	0.91	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.06	25.94	12.97	0.56	1.97
Endothelial Cells - Microvascular, donor1	11265-116G5	72.20	25.26	20.50	1.19	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	54.15	32.80	30.72	3.64	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	31.33	10.49	7.66	0.99	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	71.22	52.82	36.81	8.40	3.60
Endothelial Cells - Thoracic, donor2	11343-117G2	29.88	18.87	17.82	6.29	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	37.15	44.73	32.06	4.47	1.74
Endothelial Cells - Umbilical vein, donor2	11324-117E1	31.07	20.64	13.47	1.52	1.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	22.84	23.69	13.19	3.42	1.59
Endothelial Cells - Vein, donor1	11267-116G7	32.99	7.96	9.10	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	13.97	11.18	8.38	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	24.02	22.61	12.40	2.98	0.79
Eosinophils, donor1	12244-129H3	106.73	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	44.56	8.25	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	39.24	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	56.20	28.59	11.97	3.91	1.71
Esophageal Epithelial Cells, donor2	11587-120G3	76.97	18.72	14.56	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	227.76	0.00	0.00	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	38.18	14.78	8.62	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	20.58	16.20	7.77	2.30	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	31.09	21.78	12.03	1.73	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	28.02	35.78	28.99	5.46	3.03
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	28.52	10.24	8.05	3.55	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	28.05	17.51	10.44	0.95	1.69
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	38.47	6.32	6.06	1.32	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	35.21	18.60	14.62	3.32	1.99
Fibroblast - Cardiac, donor1	11268-116G8	47.63	25.86	18.60	2.27	0.00
Fibroblast - Cardiac, donor2	11345-117G4	25.01	6.82	8.34	2.27	0.76
Fibroblast - Cardiac, donor3	11417-118F4	18.45	13.72	10.88	1.26	1.42
Fibroblast - Cardiac, donor4	11452-119A3	22.43	20.31	8.49	1.21	0.61
Fibroblast - Cardiac, donor5	11456-119A7	39.72	25.38	15.61	1.14	0.89
Fibroblast - Cardiac, donor6	11460-119B2	39.87	36.38	15.92	4.40	1.67
Fibroblast - Choroid Plexus, donor1	11492-119E7	61.23	29.48	12.19	1.34	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	58.24	17.69	7.33	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	49.80	24.90	11.72	8.79	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	40.36	22.60	11.53	2.54	2.08
Fibroblast - Conjunctival, donor3	11692-122I9	43.76	12.72	11.36	1.87	1.19
Fibroblast - Dermal, donor1	11269-116G9	77.01	21.13	16.90	6.57	3.52
Fibroblast - Dermal, donor2	11346-117G5	49.53	23.58	17.45	8.49	1.89
Fibroblast - Dermal, donor3	11418-118F5	41.34	20.31	8.70	5.32	2.90
Fibroblast - Dermal, donor4	11450-119A1	54.15	26.11	12.43	7.57	2.83
Fibroblast - Dermal, donor5	11454-119A5	54.43	39.78	17.97	9.94	4.01
Fibroblast - Dermal, donor6	11458-119A9	66.11	44.34	20.14	14.78	4.39
Fibroblast - Gingival, donor1	11237-116D4	41.02	28.32	10.20	5.00	3.33
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	16.77	19.39	11.27	1.31	0.52
Fibroblast - Gingival, donor2	11318-117D4	37.56	38.61	13.57	5.53	2.64
Fibroblast - Gingival, donor3	11394-118C8	30.65	10.44	5.03	1.06	1.64
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	14.54	9.35	9.35	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	18.68	13.74	6.70	0.18	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	25.57	20.73	12.94	3.27	1.40
Fibroblast - Gingival, donor6 (control)	11922-125H5	21.10	22.72	10.95	2.70	1.76
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.35	3.53	0.35	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	24.28	23.84	14.48	3.22	1.75
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	17.59	27.00	14.73	3.27	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	23.47	32.58	15.36	5.05	1.10
Fibroblast - Gingival, donor9 (control)	11927-125I1	24.80	11.59	3.67	0.29	0.59
Fibroblast - Lung, donor1	11270-116H1	17.67	5.44	2.72	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	55.21	20.89	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	16.88	3.80	3.59	1.27	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	49.15	23.32	14.99	2.50	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	58.74	20.98	8.39	5.59	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	24.35	9.52	5.04	1.68	0.56
Fibroblast - Mammary, donor1	11540-120B1	34.51	32.48	12.99	4.47	2.03
Fibroblast - Mammary, donor2	11620-122A9	63.91	11.98	3.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	29.78	11.91	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	38.21	46.17	13.00	6.98	2.91
Fibroblast - Periodontal Ligament, donor2	11319-117D5	31.70	26.85	9.56	5.61	2.43
Fibroblast - Periodontal Ligament, donor3	11395-118C9	19.58	21.73	5.81	4.90	1.84
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	34.35	16.41	6.11	1.53	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	31.59	17.01	15.39	2.70	2.43
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	19.95	12.99	5.22	0.35	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	34.15	55.60	35.48	8.84	2.65
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	34.95	20.12	9.14	3.25	2.03
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	35.41	24.72	9.35	1.34	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	39.54	28.07	8.70	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	25.00	6.35	5.95	1.98	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	63.59	15.28	9.59	0.18	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	63.86	22.27	9.66	2.56	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	23.47	9.33	5.11	2.41	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	46.53	20.29	11.66	2.48	1.51
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	25.05	4.81	3.29	1.27	0.51
Fibroblast - skin normal, donor1	11553-120C5	53.98	16.57	9.52	0.82	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	31.28	9.62	6.02	1.40	1.20
Fibroblast - skin normal, donor2	11561-120D4	50.33	21.90	13.36	1.41	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	38.08	9.67	6.35	2.42	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	30.32	21.37	8.78	1.16	0.99
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	64.11	29.75	16.58	1.20	1.88
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	24.96	11.17	4.27	0.66	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	40.90	29.19	12.78	1.38	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	41.33	24.46	11.64	2.36	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	53.16	21.01	9.25	1.57	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	243.76	155.12	88.64	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	61.01	13.94	6.10	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	23.92	36.23	19.94	5.20	2.43
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	22.90	40.34	15.61	5.47	2.34
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	19.67	29.89	19.93	5.11	2.04
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	54.35	78.85	167.66	13.01	6.89
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	82.31	107.83	273.09	24.25	8.93
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	112.11	132.65	198.83	41.36	11.13
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	64.53	36.40	27.58	2.21	2.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	42.93	32.19	32.42	2.51	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	69.35	80.04	95.10	19.02	5.75
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	74.28	49.17	34.36	6.08	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	44.03	24.13	23.16	3.91	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	95.96	114.09	183.08	30.96	5.75
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	65.29	49.32	60.20	4.38	2.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	46.67	30.17	33.00	3.32	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	39.76	40.03	68.23	6.45	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	50.18	27.26	23.91	2.97	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	48.59	31.56	37.93	2.91	1.80
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	39.64	40.86	63.23	6.91	2.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	36.74	25.10	14.83	2.28	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	45.59	26.16	18.56	2.37	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	28.20	22.73	19.23	2.62	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	43.14	25.71	16.25	1.48	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	43.40	25.27	16.21	0.95	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	35.30	25.02	14.30	1.12	1.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	28.83	21.57	15.12	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	58.19	25.11	21.04	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	18.27	32.10	17.11	2.22	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	27.89	20.19	7.70	0.52	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	43.38	16.22	7.00	1.71	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	55.66	21.91	9.85	1.22	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.46	32.11	16.31	2.66	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.07	28.18	17.56	1.84	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	44.77	24.34	12.58	1.86	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	49.69	20.18	9.68	0.58	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	27.85	24.68	14.18	1.00	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	39.24	19.84	11.46	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	69.86	22.02	10.70	0.98	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	35.34	22.37	16.86	1.95	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	42.01	12.83	9.62	0.96	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	35.82	16.30	7.86	0.57	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	30.53	18.98	12.50	0.95	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	34.67	17.33	9.73	1.52	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	39.83	20.80	13.69	0.73	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	34.69	23.05	8.34	1.54	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	29.18	16.83	11.50	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	24.91	15.65	11.30	0.65	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	24.87	24.60	16.31	1.34	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	22.64	22.03	14.54	1.38	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	30.31	23.96	14.77	1.30	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	24.94	16.81	8.67	1.90	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	24.33	17.70	11.06	0.74	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	27.63	18.64	11.84	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	15.87	9.92	2.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	16.62	15.70	9.76	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	21.99	16.14	7.87	1.82	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	9.40	6.35	2.80	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	64.69	83.80	94.35	6.97	3.18
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	53.31	49.61	47.76	6.32	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	73.45	67.31	80.20	5.32	1.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	99.20	170.86	264.74	21.28	4.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	90.70	174.05	306.29	16.67	7.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	85.32	88.09	135.59	9.69	5.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	153.44	126.21	222.73	14.85	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	103.28	99.80	191.47	15.47	4.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	152.42	160.45	234.25	30.48	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	116.50	74.77	69.55	8.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	86.90	94.06	146.14	10.42	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	79.89	79.89	135.48	13.59	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	109.96	73.31	86.64	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	95.36	79.14	108.50	12.02	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	85.31	67.66	100.34	8.17	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	100.66	60.40	54.52	5.03	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	121.19	69.02	84.29	5.73	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	107.67	76.08	97.48	7.13	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	238.05	91.88	106.50	6.26	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	127.71	59.56	67.58	6.87	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	96.49	50.61	50.02	6.51	3.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	181.27	115.20	120.28	3.39	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	104.38	76.63	115.56	8.28	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	95.96	62.60	89.75	7.82	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	263.42	100.10	147.52	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	109.56	62.66	79.57	5.00	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	104.64	74.65	82.14	6.19	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	224.06	98.99	98.32	6.69	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	136.77	66.65	63.95	6.55	3.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	105.44	63.68	62.99	5.82	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	134.18	62.12	29.82	12.42	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	198.18	68.89	58.51	6.61	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	140.01	55.52	55.52	3.02	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	202.45	56.97	47.82	5.09	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	153.95	59.83	57.43	3.99	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	167.74	71.04	51.31	6.41	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	217.20	73.19	40.13	12.98	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	203.62	58.34	63.01	6.42	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	119.38	49.15	29.41	7.90	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	116.98	67.82	37.30	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	90.73	56.71	49.54	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	115.49	64.54	90.26	1.94	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	30.82	15.98	12.55	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.64	4.16	1.66	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	7.87	11.24	7.87	2.25	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	72.00	17.13	12.37	1.59	3.49
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	84.80	16.29	18.80	3.76	4.18
Hep-2 cells mock treated, biol_rep1	11898-125E8	20.77	10.68	13.00	3.60	1.86
Hep-2 cells mock treated, biol_rep2	11899-125E9	21.61	8.10	12.66	2.36	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	24.80	4.78	8.65	5.01	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	18.91	10.82	11.91	5.36	1.75
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	21.71	8.17	9.46	2.36	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	19.38	6.03	7.10	4.09	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	22.04	10.09	11.58	5.23	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	23.50	7.89	11.84	5.49	1.54
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	30.44	9.29	7.69	4.81	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	56.52	14.55	10.07	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	38.09	28.56	14.28	3.03	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	87.25	50.23	52.88	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	64.20	38.09	18.69	1.06	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	31.97	27.61	10.17	2.18	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	45.63	34.44	26.23	8.57	3.15
Hepatocyte, donor1	11523-119I2	30.27	14.53	2.42	2.42	0.00
Hepatocyte, donor2	11603-120I1	39.86	14.01	2.15	0.00	1.08
Hepatocyte, donor3	11684-122I1	30.68	14.72	2.45	2.45	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	32.63	30.02	25.45	7.18	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	24.12	31.64	8.04	2.97	1.40
Iris Pigment Epithelial Cells, donor1	11530-119I9	51.18	35.12	22.91	7.00	2.33
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	6.37	0.00	0.00	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	13.35	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	2.77	2.77	8.31	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	10.01	0.00	2.50	7.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	2.56	7.69	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	21.12	8.12	9.75	1.62	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	26.68	5.00	3.33	6.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	7.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	19.85	2.65	6.62	5.29	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	34.37	3.33	4.43	11.09	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	68.10	10.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	29.60	12.60	10.71	5.67	3.78
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	30.93	6.19	6.19	7.73	4.64
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	14.63	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.09	11.63	7.75	3.23	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	17.71	1.61	4.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	35.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	24.45	6.52	3.26	3.26	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.04	5.88	2.52	7.14	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	14.47	4.82	9.64	4.82	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	27.70	2.77	10.16	5.54	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	27.38	8.97	8.02	8.02	3.30
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	30.84	9.07	7.26	5.44	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	25.83	9.69	6.46	0.00	4.30
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	16.52	8.89	2.54	8.89	5.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	17.86	5.10	2.55	5.10	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	10.94	0.00	9.11	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	25.71	10.00	5.71	2.86	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	3.32	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	33.34	13.58	8.03	8.33	1.85
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	12.29	7.02	3.51	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	3.14	9.43	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	13.21	2.09	4.87	4.17	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	0.00	2.21	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	48.63	3.24	3.24	6.48	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	12.21	1.74	2.62	1.74	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	6.75	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	0.00	3.48	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	10.67	2.13	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	22.17	2.77	2.77	11.08	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	2.85	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	10.12	4.60	5.52	3.68	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	36.30	3.03	0.00	0.00	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	20.09	2.11	3.17	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	8.40	10.04	6.45	4.73	1.63
Keratinocyte - epidermal, donor2	11349-117G8	11.71	5.27	9.37	1.17	1.17
Keratinocyte - epidermal, donor3	11421-118F8	43.92	37.48	13.73	8.05	3.41
Keratinocyte - oral, donor1	11251-116E9	52.45	47.90	14.19	8.51	4.54
Keratocytes, donor1	11527-119I6	40.23	35.07	13.75	2.06	3.09
Keratocytes, donor2	11607-120I5	51.56	22.26	16.41	4.69	4.69
Keratocytes, donor3	11688-122I5	29.05	9.68	6.92	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	19.78	13.19	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	78.75	48.54	15.10	4.31	2.16
Lens Epithelial Cells, donor2	11609-120I7	43.60	20.88	8.42	0.69	0.46
Lens Epithelial Cells, donor3	11690-122I7	33.70	26.74	15.64	1.92	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	34.98	33.68	20.51	2.49	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	33.21	22.61	19.26	0.84	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	37.94	32.43	22.98	1.73	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	66.14	26.89	17.21	2.69	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	21.75	16.39	17.33	1.26	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	33.64	31.05	25.23	0.75	1.62
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	47.20	23.80	15.18	1.23	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	24.02	24.02	15.42	1.26	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	29.56	25.19	17.59	1.69	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	54.19	23.73	21.75	3.16	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	31.99	22.88	18.23	1.36	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	27.77	22.96	17.22	0.93	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	51.22	21.25	21.25	2.09	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	23.61	21.71	15.50	0.95	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	29.53	28.57	21.01	1.65	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	41.88	20.33	19.40	2.77	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	27.43	26.19	18.08	2.18	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	25.80	31.11	20.68	1.46	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	51.01	23.70	18.10	1.97	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	23.72	26.65	18.45	0.59	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	27.88	32.11	22.90	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	55.77	26.19	19.88	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	36.09	28.01	23.43	1.35	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	31.64	25.89	23.46	2.57	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	57.54	22.81	15.55	1.56	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	27.43	21.78	18.85	1.68	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	29.32	28.57	19.70	2.11	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	74.29	22.01	22.01	3.44	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	28.03	21.83	19.94	2.07	1.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	24.49	20.04	20.04	0.74	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	50.40	22.29	17.93	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	21.50	18.85	15.55	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	29.49	17.72	19.70	1.61	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	57.38	25.17	18.14	1.48	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	27.18	21.99	20.01	0.99	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	29.97	19.25	19.25	1.65	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	48.25	20.91	16.08	1.93	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	26.17	24.65	16.74	1.52	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	39.05	26.17	19.88	2.38	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	49.07	29.16	16.71	1.42	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	28.60	13.09	18.91	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	24.27	19.14	22.25	1.40	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	53.36	26.14	21.13	1.43	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	30.05	11.76	14.37	1.63	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	32.02	24.95	21.19	1.65	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	33.17	26.98	19.80	2.72	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	25.36	15.37	13.57	0.77	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	61.76	27.45	16.41	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	11.33	13.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	29.92	9.97	3.84	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	36.37	2.97	8.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	15.66	8.04	7.19	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	31.65	7.74	5.63	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	32.69	3.74	3.74	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.22	8.24	7.21	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	41.63	8.33	2.38	0.00	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.29	7.24	7.92	1.36	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	31.12	8.43	8.43	0.87	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	41.87	14.41	9.00	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.45	10.16	4.47	0.54	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.00	6.68	7.19	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	33.52	7.41	6.35	1.76	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	51.31	8.00	5.33	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.51	9.17	4.58	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	38.69	12.81	7.47	0.80	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	40.62	13.42	9.83	1.70	1.70
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	21.47	7.98	4.29	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	31.80	8.15	7.34	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	34.78	12.91	8.33	2.50	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	36.15	13.17	8.41	2.52	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	30.91	11.33	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	34.26	12.77	8.13	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	32.58	12.85	5.98	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	40.94	9.96	3.87	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	22.62	5.30	6.36	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	27.66	15.12	5.53	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	29.93	3.45	3.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	26.48	6.91	3.84	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	21.51	9.62	7.93	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	31.18	10.67	10.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	21.24	5.87	8.13	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	35.19	6.46	6.46	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	41.83	5.98	4.48	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	17.46	5.95	3.34	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	30.58	9.48	6.03	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	39.39	9.42	7.71	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	29.99	6.00	6.00	0.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	20.51	4.83	4.83	3.02	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	20.62	3.55	2.84	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	24.06	5.16	4.47	1.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	22.54	8.59	8.05	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	30.97	9.43	6.06	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	24.45	6.67	5.56	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	24.42	6.98	5.81	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	24.33	1.06	6.35	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	17.61	7.60	6.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	16.72	2.91	4.36	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.93	6.90	3.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	35.02	7.40	4.93	1.97	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	23.52	13.17	1.88	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	21.12	4.02	4.53	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	22.53	9.01	7.21	0.45	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	6.88	5.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	31.62	7.57	6.23	0.89	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	20.72	8.21	6.26	0.39	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.75	7.26	9.24	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	28.02	10.90	3.11	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	27.13	8.75	7.88	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	24.60	13.98	5.59	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	23.41	8.83	2.65	1.32	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	25.46	8.87	5.40	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.74	11.14	7.09	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	22.59	5.29	6.73	1.92	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	18.68	8.75	6.36	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	27.95	8.51	5.47	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	22.13	12.45	7.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	23.18	9.50	4.18	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	20.66	6.71	2.58	1.55	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	26.60	9.67	5.44	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	19.96	9.19	4.75	0.63	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	17.59	6.40	3.73	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	29.31	8.05	8.62	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	23.65	7.71	4.63	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	18.39	7.78	4.24	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	22.13	8.51	10.21	0.57	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.55	7.90	3.74	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	17.23	5.48	3.92	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	17.12	6.26	5.01	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	16.26	8.83	4.65	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.04	4.68	2.68	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	20.32	10.69	4.81	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	18.99	12.53	4.85	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	19.27	5.51	8.26	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	21.34	10.67	9.78	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	29.63	14.25	7.98	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	18.41	8.44	3.07	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	29.00	12.04	8.21	1.64	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	18.71	12.03	4.01	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	14.82	7.02	5.46	0.52	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	29.18	11.27	10.61	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	31.18	24.94	12.47	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	13.45	8.89	1.37	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	10.46	11.74	1.10	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	10.09	10.62	2.49	0.79	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	44.07	73.28	59.47	14.34	3.19
Mallassez-derived cells, donor2	11929-125I3	32.17	35.18	20.92	2.38	1.11
Mallassez-derived cells, donor3	11930-125I4	54.90	53.51	41.42	13.90	3.75
Mammary Epithelial Cell, donor1	11273-116H4	32.38	16.34	20.83	5.58	3.19
Mammary Epithelial Cell, donor2	11350-117G9	79.63	20.27	29.24	5.50	0.87
Mammary Epithelial Cell, donor3	11422-118F9	12.72	7.23	9.73	1.00	1.50
Mast cell - stimulated, donor1	11487-119E2	26.44	21.69	3.39	0.00	0.00
Mast cell, donor1	11563-120D6	49.64	6.92	2.81	0.32	0.11
Mast cell, donor2	11565-120D8	72.81	7.13	0.89	0.30	0.30
Mast cell, donor3	11566-120D9	76.32	10.36	0.68	0.45	0.90
Mast cell, donor4	11567-120E1	56.38	8.51	0.53	0.18	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	34.71	15.86	3.66	1.00	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	34.44	21.60	8.76	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	37.86	8.49	1.61	0.92	0.80
Mast cell, expanded, donor8	11941-126A6	33.31	8.70	4.85	0.17	0.50
Melanocyte - dark, donor1	11502-119F8	45.27	36.62	28.16	1.09	1.19
Melanocyte - dark, donor2	11582-120F7	63.68	26.30	15.23	2.08	1.38
Melanocyte - dark, donor3	11663-122F7	20.50	25.50	5.29	3.55	1.09
Melanocyte - light, donor1	11274-116H5	4.47	7.05	1.65	0.47	0.00
Melanocyte - light, donor2	11351-117H1	6.14	3.41	2.05	0.00	0.00
Melanocyte - light, donor3	11423-118G1	5.20	6.94	0.00	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	39.36	33.42	6.77	3.85	1.46
Melanocyte, donor2 (MC+2)	12739-135I3	26.89	23.67	8.07	0.81	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	39.64	13.12	5.09	0.27	0.27
Meningeal Cells, donor1	11493-119E8	43.92	38.09	15.63	3.23	1.61
Meningeal Cells, donor2	11573-120E7	70.86	40.05	14.08	2.20	1.32
Meningeal Cells, donor3	11654-122E7	21.19	40.34	21.27	8.15	2.77
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	38.50	39.07	21.10	6.56	4.56
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	26.87	20.13	15.40	3.02	1.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	39.42	5.26	2.63	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	28.78	17.01	9.16	5.23	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	29.42	25.12	21.53	8.61	3.59
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	55.06	11.22	7.62	1.27	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	34.68	16.59	10.56	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	56.26	36.92	16.70	10.77	3.96
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	40.18	43.10	25.57	16.80	5.84
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	40.10	25.98	22.51	6.14	1.64
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	69.39	28.95	9.14	3.19	2.91
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	44.61	16.36	2.97	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	28.81	23.55	5.53	1.84	2.37
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	72.11	14.84	11.57	0.59	1.78
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	32.70	7.01	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	24.98	34.58	24.98	12.17	3.20
Mesenchymal stem cells - adipose, donor0	11217-116B2	29.77	43.60	20.20	17.01	4.61
Mesenchymal stem cells - hepatic, donor0	11218-116B3	45.03	21.89	7.82	1.56	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	74.75	44.27	29.75	13.79	4.35
Mesothelial Cells, donor1	11247-116E5	25.72	39.78	9.28	3.45	1.59
Mesothelial Cells, donor2	12156-128G5	17.52	29.03	20.52	3.00	1.00
Mesothelial Cells, donor3	11402-118D7	15.61	21.75	4.99	0.58	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	2.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	32.02	9.36	1.48	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	12.37	9.42	1.77	1.18	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	29.13	10.23	2.17	0.93	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.37	8.92	2.28	0.62	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	28.03	5.76	1.25	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.05	4.19	2.79	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	24.18	6.30	1.42	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	5.54	3.56	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	37.17	5.31	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	12.92	11.78	2.28	0.76	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	26.74	8.70	1.91	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	10.43	2.98	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.08	5.02	2.51	1.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.61	6.18	1.90	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	21.64	5.76	1.15	0.92	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.52	7.78	3.37	0.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	15.90	6.52	1.63	0.61	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	27.25	7.29	1.50	0.64	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.89	3.56	0.89	0.44	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	16.86	5.69	1.75	0.66	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.52	4.56	0.00	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	17.67	4.62	1.63	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6.18	5.29	1.47	0.59	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	2.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	27.87	9.13	2.40	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	7.20	7.20	2.00	1.60	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	2.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	24.53	8.01	2.50	0.50	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	2.04	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	27.59	6.57	2.19	0.88	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	4.41	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.92	1.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	24.05	6.94	4.71	1.24	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.74	1.39	1.39	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	21.54	8.55	2.39	0.68	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.81	3.50	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	2.13	1.42	0.71	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.11	9.82	2.52	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	6.23	4.16	1.25	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.75	0.58	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.75	3.92	2.41	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.18	7.51	3.76	0.83	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.01	4.62	3.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	11.38	2.28	2.28	1.14	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.88	3.73	1.11	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.63	7.26	3.11	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.87	5.15	1.29	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.64	3.18	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.94	3.74	1.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	15.57	8.98	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.09	3.39	0.42	0.00	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	16.88	7.64	2.55	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	14.37	7.30	1.77	0.66	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1.90	2.28	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	14.49	9.38	1.42	0.28	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	16.96	11.55	2.70	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	2.61	0.65	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	11.47	4.41	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	17.30	8.94	1.44	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	5.77	2.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	10.42	4.76	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	79.10	26.37	7.53	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	57.03	14.26	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	40.74	11.50	0.99	0.99	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	36.82	10.52	8.42	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	41.71	12.65	1.19	0.59	1.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	37.25	5.59	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	39.43	9.76	1.13	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	28.50	6.92	2.66	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	26.01	9.05	1.58	0.45	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	39.78	7.37	0.74	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	24.55	7.69	1.10	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	4.67	6.22	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	47.56	17.64	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	57.96	11.59	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	32.32	4.04	0.00	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.77	8.85	5.06	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	70.82	13.62	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	92.83	6.99	2.54	0.00	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	89.89	17.01	4.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	57.40	15.10	6.04	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	5.71	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	110.92	3.26	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	4.75	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	58.38	28.87	14.65	3.45	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	37.11	13.07	8.88	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	5.34	14.02	4.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.01	8.76	1.25	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	25.48	19.39	9.32	1.33	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	94.16	27.13	14.36	6.38	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.16	8.84	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	38.59	22.05	14.70	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.63	8.79	3.35	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.25	15.57	5.58	1.39	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	9.19	10.27	0.81	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	43.73	10.09	8.62	0.84	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	22.27	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	17.37	8.44	5.46	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.95	14.07	3.79	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.01	10.65	3.63	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	5.39	8.98	1.47	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	39.55	14.22	8.38	0.91	1.64
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	12.20	13.79	3.71	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.00	7.20	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	27.24	21.99	10.83	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.43	8.29	2.44	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	50.80	15.87	9.17	1.06	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.14	14.06	2.81	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	14.25	8.73	1.38	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.32	10.28	3.53	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	38.28	15.18	10.00	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	65.74	20.23	12.64	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	35.87	13.37	4.68	0.89	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.28	14.40	6.77	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.61	9.49	3.09	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	27.47	12.45	5.58	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	99.31	27.08	54.17	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.00	6.66	3.00	0.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	30.21	18.03	6.76	1.35	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.92	10.32	5.56	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	10.22	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	35.95	12.86	6.05	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.75	8.15	1.96	1.30	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.64	6.10	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	45.68	20.35	7.69	3.17	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.93	8.82	7.06	2.65	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	16.62	8.64	1.33	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.88	7.44	1.98	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.16	6.89	1.91	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.73	7.56	1.51	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	31.39	15.03	3.54	1.77	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	12.20	4.74	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	15.33	5.11	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	17.68	8.54	1.83	0.61	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.24	6.29	1.57	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	11.80	3.33	0.30	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	8.70	1.58	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	45.35	10.20	7.94	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	25.29	20.23	0.00	0.00
Myoblast, donor1	11241-116D8	24.97	32.30	30.19	12.67	2.36
Myoblast, donor2	11322-117D8	22.63	23.40	10.16	2.11	1.73
Myoblast, donor3	11398-118D3	28.59	19.17	17.15	5.89	2.52
NK T cell leukemia cell line:KHYG-1	10777-110G3	48.74	13.72	6.71	0.44	0.73
Natural Killer Cells, donor1	11230-116C6	115.93	8.61	4.31	0.92	1.54
Natural Killer Cells, donor2	11311-117C6	105.24	5.13	2.11	1.51	0.90
Natural Killer Cells, donor3	11387-118C1	88.53	4.97	3.13	0.55	0.18
Neural stem cells, donor1	11275-116H6	13.79	24.32	7.98	1.09	0.00
Neural stem cells, donor2	11352-117H2	40.44	21.18	7.70	0.00	0.00
Neurons, donor1	11494-119E9	76.24	42.10	13.65	1.14	1.14
Neurons, donor2	11574-120E8	25.54	24.00	12.33	0.88	0.44
Neurons, donor3	11655-122E8	50.97	36.18	14.80	3.29	3.29
Neutrophils, donor1	11233-116C9	21.34	14.85	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	11.60	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	40.93	11.00	1.83	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	38.59	16.62	11.04	0.59	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	31.26	10.74	7.81	0.98	1.95
Nucleus Pulposus Cell, donor3	11462-119B4	77.01	19.85	8.22	1.60	1.00
Olfactory epithelial cells, donor1	11933-125I7	28.91	15.97	4.82	1.38	2.20
Olfactory epithelial cells, donor2	11934-125I8	36.62	24.61	12.74	2.46	0.87
Olfactory epithelial cells, donor3	11935-125I9	28.04	19.07	9.53	1.82	1.02
Olfactory epithelial cells, donor4	11936-126A1	30.29	16.95	4.77	1.56	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	46.94	37.91	13.84	7.82	3.61
Osteoblast - differentiated, donor1	11276-116H7	27.01	6.59	4.47	0.85	0.21
Osteoblast - differentiated, donor2	11353-117H3	19.43	9.14	2.29	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	45.31	7.45	2.48	0.00	0.00
Osteoblast, donor1	11277-116H8	14.85	11.53	15.05	2.15	1.17
Osteoblast, donor2	11354-117H4	44.25	34.41	16.86	7.02	0.70
Osteoblast, donor3	11426-118G4	20.79	17.95	11.37	2.13	0.36
Pancreatic stromal cells, donor1	11249-116E7	25.35	19.21	10.02	2.53	1.94
Pericytes, donor1	11491-119E6	42.39	17.36	5.67	0.56	0.33
Pericytes, donor2	11571-120E5	86.47	19.92	5.89	0.68	1.58
Pericytes, donor3	11652-122E5	55.75	37.03	13.43	5.49	3.05
Perineurial Cells, donor1	11499-119F5	60.92	36.62	11.08	3.39	2.26
Perineurial Cells, donor2	11579-120F4	43.89	26.13	18.95	3.04	1.56
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	95.94	4.78	1.59	1.27	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	54.36	3.43	0.73	0.49	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	53.06	6.21	1.81	0.39	0.52
Placental Epithelial Cells, donor1	11278-116H9	21.29	44.25	9.09	2.87	2.15
Placental Epithelial Cells, donor2	11355-117H5	32.16	6.65	3.33	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	16.69	14.72	6.09	1.18	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.67	14.87	4.43	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	15.01	19.13	11.82	0.75	1.31
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	14.10	8.75	5.09	1.04	0.13
Preadipocyte - breast, donor2	11328-117E5	34.00	16.21	11.26	0.68	0.00
Preadipocyte - omental, donor1	11468-119C1	15.66	18.65	8.95	1.39	1.49
Preadipocyte - omental, donor2	11329-117E6	20.95	19.20	8.73	2.18	0.44
Preadipocyte - omental, donor3	11403-118D8	20.63	19.63	9.60	2.86	0.57
Preadipocyte - perirenal, donor1	11469-119C2	52.17	19.69	14.76	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	6.76	6.14	7.37	1.84	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	30.63	28.51	19.66	7.44	1.95
Preadipocyte - subcutaneous, donor3	11428-118G6	45.98	29.29	20.09	5.45	2.72
Preadipocyte - visceral, donor1	11280-116I2	28.04	31.58	23.75	9.04	3.63
Preadipocyte - visceral, donor2	11357-117H7	14.73	19.79	14.27	4.14	0.92
Preadipocyte - visceral, donor3	11429-118G7	44.72	23.82	21.32	5.43	3.24
Prostate Epithelial Cells (polarized), donor1	11253-116F2	25.80	31.38	10.11	4.98	2.87
Prostate Epithelial Cells, donor2	11331-117E8	17.87	21.94	18.96	4.20	1.49
Prostate Epithelial Cells, donor3	11404-118D9	19.04	13.47	5.02	3.25	2.02
Prostate Stromal Cells, donor1	11254-116F3	24.26	29.61	24.83	9.00	2.85
Prostate Stromal Cells, donor2	11332-117E9	27.07	27.79	13.27	6.81	2.33
Prostate Stromal Cells, donor3	11405-118E1	36.29	14.18	9.07	2.19	1.77
Renal Cortical Epithelial Cells, donor1	11516-119H4	55.84	27.74	12.04	1.82	1.82
Renal Cortical Epithelial Cells, donor2	11596-120H3	15.87	32.58	11.71	2.91	1.04
Renal Epithelial Cells, donor1	11517-119H5	31.96	14.20	8.62	2.54	3.04
Renal Epithelial Cells, donor2	11597-120H4	33.43	32.01	20.63	4.27	0.71
Renal Epithelial Cells, donor3	11678-122H4	18.42	35.15	13.02	1.91	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	53.79	17.02	8.17	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	52.42	31.27	15.77	4.58	1.89
Renal Glomerular Endothelial Cells, donor3	11675-122H1	36.19	30.19	21.31	5.99	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.29	11.31	5.99	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	45.12	29.93	18.27	3.96	1.10
Renal Mesangial Cells, donor2	11598-120H5	33.86	21.94	15.05	2.51	0.63
Renal Mesangial Cells, donor3	11679-122H5	23.03	16.64	8.88	1.94	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	50.46	45.09	16.11	6.71	1.88
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	29.94	26.99	12.23	2.95	2.53
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	22.76	29.70	18.13	4.24	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	40.45	34.48	12.96	8.30	4.93
Retinal Pigment Epithelial Cells, donor1	11528-119I7	82.43	41.50	15.63	2.27	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	27.79	33.96	9.26	5.15	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	20.83	19.57	14.80	0.50	1.76
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	23.25	22.32	2.67	0.40	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	45.56	20.55	13.40	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	82.56	26.42	37.98	3.85	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	52.78	19.72	21.46	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	34.20	16.64	22.62	1.82	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	20.85	13.01	18.07	1.39	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	20.97	16.84	22.53	2.34	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	35.35	23.57	31.88	2.73	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	22.73	19.58	20.75	2.45	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	31.67	18.95	28.20	3.70	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	44.63	14.92	17.39	0.96	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	25.72	15.58	21.78	2.72	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	20.79	18.28	23.12	2.33	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	54.23	17.21	17.65	1.00	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	23.93	15.99	20.71	2.36	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	36.07	19.47	24.12	2.66	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	63.09	13.38	15.49	1.53	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	19.66	12.67	15.00	1.02	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	17.66	20.29	21.61	1.88	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	39.41	12.08	14.07	0.93	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	24.14	13.53	17.23	1.95	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	24.63	18.90	19.29	3.44	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	41.76	12.28	14.95	1.50	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	24.39	14.86	14.30	2.80	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	19.48	16.58	17.09	1.37	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	34.46	14.22	16.41	1.28	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	21.58	12.51	15.70	1.35	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.54	16.52	20.28	1.75	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	74.30	22.88	21.70	1.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	23.41	12.90	18.25	2.98	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	32.97	19.64	26.66	2.34	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	69.26	22.39	20.32	1.45	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	24.78	14.38	19.47	3.10	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	25.48	17.34	20.26	1.67	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	47.78	17.50	20.19	2.42	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	21.29	11.24	12.60	2.04	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	22.56	16.97	15.62	2.31	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	65.34	22.70	25.10	1.72	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	19.48	12.48	14.68	0.55	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	29.55	18.22	25.45	3.61	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	54.03	16.87	17.55	1.02	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	21.75	13.17	17.75	1.92	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	23.46	12.79	15.99	2.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	63.33	10.09	14.79	0.55	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	33.33	8.10	18.10	1.43	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	27.41	9.27	17.13	1.21	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	58.01	7.16	19.49	0.94	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	40.18	12.58	16.77	1.75	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	24.18	8.16	14.51	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	44.06	12.48	16.89	1.35	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	36.24	19.94	22.85	1.60	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	41.98	13.99	20.08	3.04	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	70.23	15.07	20.80	0.60	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	21.26	7.92	10.18	0.68	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	19.77	8.69	7.49	0.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	30.35	11.69	17.95	0.94	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.33	9.39	14.30	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	28.25	11.42	18.03	0.60	1.20
Schwann Cells, donor1	11498-119F4	41.94	27.65	11.28	2.26	1.69
Schwann Cells, donor2	11578-120F3	54.44	20.41	3.40	3.40	0.00
Schwann Cells, donor3	11659-122F3	34.18	24.54	9.42	1.75	0.88
Sebocyte, donor1	11220-116B5	27.39	35.61	20.82	7.12	1.10
Sebocyte, donor2	11301-117B5	22.98	33.09	21.60	9.65	4.14
Sebocyte, donor3	11378-118B1	32.15	24.32	12.99	5.98	2.06
Sertoli Cells, donor1	11255-116F4	18.22	21.54	11.60	3.31	1.66
Sertoli Cells, donor2	11333-117F1	16.95	19.77	14.12	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	17.42	11.44	9.15	1.58	1.14
Skeletal Muscle Cells, donor2	11358-117H8	10.84	1.45	5.06	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	15.88	8.36	6.69	2.51	0.84
Skeletal Muscle Cells, donor4	11451-119A2	77.76	52.78	26.55	18.54	9.43
Skeletal Muscle Cells, donor5	11455-119A6	60.80	52.32	21.40	14.27	4.31
Skeletal Muscle Cells, donor6	11459-119B1	71.56	46.63	23.70	21.55	8.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	46.75	48.76	19.03	6.17	4.16
Skeletal Muscle Satellite Cells, donor2	11321-117D7	39.52	28.54	13.13	6.56	3.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	40.87	36.81	18.95	13.89	5.06
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	27.38	20.56	16.93	1.85	1.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	9.41	13.03	8.69	0.00	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	27.11	10.87	9.91	1.24	0.41
Skin - palm, donor1	10286-104F7	59.09	2.69	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	19.89	19.61	10.67	2.02	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	52.35	17.18	17.18	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.34	19.73	13.11	2.21	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	22.94	25.72	21.69	3.06	1.39
Small Airway Epithelial Cells, donor2	11334-117F2	25.18	14.77	14.21	1.13	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	64.70	21.78	15.01	4.65	1.90
Small Airway Epithelial Cells, donor3	11406-118E2	10.79	9.97	6.97	1.12	0.67
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	191.63	32.71	23.76	4.32	3.39
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	25.57	6.89	4.45	2.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	18.22	15.87	7.05	1.76	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	12.82	16.80	7.51	3.31	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	18.51	21.66	13.78	3.54	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.81	14.68	6.18	3.09	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	44.03	17.01	10.01	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	21.29	15.04	11.58	3.46	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	53.20	30.81	15.29	2.66	3.10
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	67.60	40.84	37.00	6.53	3.07
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	41.35	42.65	19.21	1.95	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	36.33	41.94	14.18	3.25	2.95
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	33.74	25.91	12.39	2.56	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	51.89	36.44	9.27	4.39	1.30
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	32.57	7.61	4.26	0.61	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	28.54	13.13	9.85	1.77	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.20	5.25	7.15	1.43	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	27.43	36.87	14.30	3.54	2.21
Smooth Muscle Cells - Colonic, donor2	11320-117D6	52.30	27.12	18.30	6.89	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	39.25	33.80	18.79	8.61	3.88
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	13.46	20.11	15.00	3.71	1.55
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	51.74	19.40	34.49	7.55	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	31.98	25.40	19.72	3.29	2.39
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	32.09	33.80	10.92	3.41	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	30.08	29.29	10.99	1.26	2.12
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	18.72	22.74	12.08	7.25	4.03
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	31.17	28.67	15.02	2.73	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	26.57	11.47	10.26	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	56.69	50.60	29.67	33.38	14.04
Smooth Muscle Cells - Prostate, donor1	11257-116F6	56.99	24.90	11.85	3.73	1.60
Smooth Muscle Cells - Prostate, donor2	11335-117F3	41.45	16.78	16.53	3.88	3.51
Smooth Muscle Cells - Prostate, donor3	11465-119B7	31.71	10.40	5.83	0.25	2.28
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	19.75	26.99	14.62	4.37	1.96
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.75	5.25	4.50	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	20.68	18.09	10.34	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.98	11.16	4.65	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	20.70	17.67	16.16	4.04	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	19.74	17.55	15.67	1.88	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	38.64	35.10	9.44	5.01	2.65
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	31.66	36.57	13.16	6.25	2.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	18.22	21.96	4.67	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	20.44	22.60	18.28	3.31	1.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	25.24	22.69	17.34	5.10	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	28.96	20.31	12.79	2.26	1.32
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	45.84	35.50	15.09	6.57	1.96
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	69.46	37.96	15.33	3.35	2.18
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	38.09	10.95	2.86	2.38	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	19.08	24.22	15.66	2.69	1.71
Smooth Muscle Cells - Uterine, donor1	11258-116F7	60.76	30.71	13.04	5.08	2.43
Smooth Muscle Cells - Uterine, donor3	11466-119B8	45.06	19.60	9.36	8.48	2.34
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	38.29	13.02	6.61	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	36.49	17.72	9.52	1.06	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	108.24	25.66	15.99	1.49	2.98
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	52.46	17.61	8.98	2.16	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	30.38	17.32	12.21	5.11	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	73.26	31.12	20.48	9.06	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	65.77	19.30	9.40	2.29	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	55.11	12.38	7.99	0.40	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	69.81	22.99	14.63	0.84	3.34
Smooth muscle cells - airway, control, donor4	11969-126D7	71.96	16.96	9.63	1.83	1.83
Synoviocyte, donor1	11291-117A4	25.75	25.75	11.95	2.52	1.01
Synoviocyte, donor2	11368-117I9	33.86	14.25	5.36	0.00	0.67
Synoviocyte, donor3	11440-118H9	47.36	10.05	5.59	0.45	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	50.03	24.30	12.15	10.36	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	29.73	7.93	9.91	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	16.21	9.72	6.71	1.16	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	28.75	29.46	13.62	9.89	3.73
Tracheal Epithelial Cells, donor2	11369-118A1	12.76	11.21	11.98	5.80	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	14.89	8.02	3.44	2.29	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	22.02	17.84	3.20	0.12	0.25
Urethra, donor2	10319-105A4	19.78	3.60	7.19	0.00	0.00
Urothelial Cells, donor1	11520-119H8	59.77	31.35	12.22	4.25	1.59
Urothelial Cells, donor2	11600-120H7	34.05	19.23	9.61	2.80	2.00
Urothelial Cells, donor3	11681-122H7	22.00	18.11	4.13	1.38	1.15
Urothelial cells, donor0	11216-116B1	35.66	30.31	8.02	2.67	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	126.35	12.46	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	148.68	11.44	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	49.97	8.21	2.05	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	63.01	10.67	0.69	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	65.66	8.72	1.74	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	129.11	4.16	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	154.19	11.01	1.84	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	41.08	10.04	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	52.06	36.02	27.02	5.92	0.99
Wilms' tumor cell line:HFWT	10597-108E3	18.48	13.20	12.32	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	43.85	9.22	7.26	5.87	3.91
achilles tendon, donor2	10292-104G4	47.53	6.20	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	44.11	42.58	44.87	9.18	3.31
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	89.39	39.93	40.17	6.73	5.57
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	44.16	15.31	17.69	1.78	1.90
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	105.31	79.46	93.34	13.06	5.17
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	25.02	16.30	7.59	1.97	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	74.23	27.07	34.68	2.11	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	105.62	11.71	42.19	2.72	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	169.21	31.29	33.93	9.25	6.61
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	107.81	17.56	36.75	2.04	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	151.44	19.03	45.82	3.11	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	79.30	39.38	41.40	30.73	8.28
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	187.22	39.01	35.10	11.70	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	113.63	56.00	75.52	8.37	2.79
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	160.78	54.89	67.57	27.70	9.58
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	121.57	53.77	36.53	13.15	10.23
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	38.58	16.27	10.69	2.32	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	55.11	13.98	15.63	3.29	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	15.65	20.57	6.14	0.92	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	38.40	34.14	14.93	11.95	3.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	36.09	24.57	16.98	7.58	4.25
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	38.27	31.53	26.24	8.91	2.89
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	47.89	28.51	26.51	16.93	6.46
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	46.03	31.35	19.01	12.01	3.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	102.20	57.60	16.72	3.72	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	65.92	54.62	30.89	10.55	3.39
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	56.26	16.14	36.20	2.18	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	93.72	29.99	22.49	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	73.71	14.13	5.89	2.35	2.12
adipose tissue, adult, pool1	10010-101C1	17.22	7.76	0.78	0.00	0.31
adipose, donor1	10184-103D4	209.35	69.20	70.96	6.45	1.17
adipose, donor2	10185-103D5	62.86	16.63	10.95	2.03	1.22
adipose, donor3	10186-103D6	45.47	31.31	26.14	4.90	1.91
adipose, donor4	10187-103D7	65.87	58.07	91.01	9.53	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	35.04	14.99	9.31	3.63	1.26
adrenal gland, adult, pool1	10081-102A9	3.64	18.19	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	26.55	10.41	3.07	2.27	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	41.45	15.72	8.22	5.36	1.43
amniotic membrane cells, donor1	12235-129G3	39.41	13.22	4.64	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	51.73	16.91	4.06	0.68	0.68
amniotic membrane cells, donor3	12237-129G5	46.55	16.20	3.24	0.29	0.59
amygdala - adult, donor10196	10167-103B5	30.83	20.16	1.19	2.37	1.19
amygdala, adult, donor10252	10151-102I7	15.41	13.38	1.22	1.01	0.61
amygdala, newborn, donor10223	10360-105E9	17.43	20.98	4.20	2.26	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	33.11	15.15	5.60	0.64	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	99.72	51.63	45.45	7.94	5.74
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	65.14	10.02	34.74	1.00	0.67
aorta, adult, pool1	10052-101G7	33.15	5.69	0.78	0.00	0.39
appendix, adult	10189-103D9	45.02	10.87	4.66	1.94	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	57.78	41.62	33.36	5.16	2.75
artery, adult	10190-103E1	40.76	17.66	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	55.19	75.77	28.68	2.03	0.72
b cell line:RPMI1788	10427-106D4	54.42	16.36	17.40	4.91	6.84
basal cell carcinoma cell line:TE 354.T	10702-109G9	21.36	17.20	6.94	1.66	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	28.98	17.86	11.31	6.25	3.08
bile duct carcinoma cell line:TFK-1	10496-107C1	25.11	15.57	5.86	2.68	1.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	78.29	11.74	12.86	2.24	2.80
bladder, adult, pool1	10011-101C2	25.97	9.56	2.82	0.33	0.54
blood, adult, pool1	10053-101G8	77.51	8.86	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	37.68	17.13	9.42	0.00	0.00
bone marrow, adult	10192-103E3	23.62	9.45	4.72	2.02	0.00
brain, adult, donor1	10084-102B3	18.45	7.18	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	14.25	11.25	0.89	0.22	0.11
brain, fetal, pool1	10085-102B4	42.74	26.71	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	39.97	17.84	14.87	1.65	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	24.09	16.98	5.62	0.75	0.50
breast, adult, donor1	10080-102A8	29.67	5.68	1.26	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	54.37	32.27	5.72	10.04	5.46
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	71.74	27.21	9.28	6.18	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	49.50	17.96	10.82	3.91	2.30
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	31.96	16.46	5.57	3.15	0.97
carcinoid cell line:NCI-H1770	10703-109H1	35.26	20.69	4.23	5.64	0.94
carcinoid cell line:NCI-H727	10735-110B6	27.89	14.77	9.63	3.06	0.77
carcinoid cell line:SK-PN-DW	10719-109I8	112.81	56.09	33.27	10.14	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	65.21	18.10	8.78	1.06	1.33
caudate nucleus - adult, donor10196	10177-103C6	58.72	12.66	0.00	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	13.55	13.39	1.84	0.33	0.17
caudate nucleus, adult, donor10258	10379-105H1	43.56	17.58	4.58	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	25.27	26.00	5.86	1.10	0.00
cerebellum - adult, donor10196	10173-103C2	61.18	11.65	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	22.42	9.39	0.21	0.00	0.85
cerebellum, adult, pool1	10083-102B2	30.01	8.97	0.00	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	28.23	9.96	4.98	0.00	0.83
cerebral meninges, adult	10188-103D8	19.41	15.88	1.51	1.51	1.01
cerebrospinal fluid, donor2	10294-104G6	20.46	5.85	2.92	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	46.87	17.40	12.80	4.03	2.59
cervical cancer cell line:ME-180	10553-107I4	32.98	22.70	6.63	1.16	0.99
cervix, adult, pool1	10013-101C4	27.93	9.24	4.62	0.42	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	18.95	15.88	5.71	0.70	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	28.74	13.06	7.84	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	40.39	39.52	29.83	9.32	3.73
choriocarcinoma cell line:SCH	10785-110H2	39.06	23.16	11.71	1.36	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	35.81	9.01	10.20	2.37	1.42
chorionic membrane cells, donor1	12238-129G6	34.48	15.96	7.69	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	31.02	27.64	10.54	2.98	0.80
chorionic membrane cells, donor3	12240-129G8	43.41	21.98	18.68	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	103.00	52.51	89.87	9.09	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	100.08	42.07	31.31	7.49	3.27
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	115.31	60.61	37.38	3.59	3.17
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	56.50	29.02	15.15	13.87	6.68
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	60.71	32.41	11.37	12.58	5.08
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	52.94	29.93	17.71	14.05	5.29
chronic myelogenous leukemia cell line:K562	10454-106G4	53.59	79.50	37.10	29.15	11.48
chronic myelogenous leukemia cell line:KU812	10409-106B4	66.46	64.11	50.30	4.17	3.65
clear cell carcinoma cell line:JHOC-5	10638-108I8	28.34	20.12	15.31	1.37	0.91
clear cell carcinoma cell line:TEN	10636-108I6	49.97	21.17	13.71	4.68	3.47
colon carcinoma cell line:CACO-2	10513-107D9	30.75	24.16	18.12	9.15	2.56
colon carcinoma cell line:COLO-320	10420-106C6	129.23	49.41	36.87	14.82	7.60
colon, adult, donor1	10082-102B1	28.56	11.90	3.57	0.00	0.00
colon, adult, pool1	10014-101C5	34.55	10.81	3.17	0.82	0.47
colon, fetal, donor1	10070-101I7	51.91	13.60	4.94	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	18.33	0.00	13.75	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	300.44	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	31.02	22.95	24.22	8.92	4.67
cord blood derived cell line:COBL-a 24h infection	10453-106G3	34.26	31.09	28.53	15.70	5.13
cord blood derived cell line:COBL-a untreated	10449-106F8	47.10	34.69	34.97	15.51	5.50
corpus callosum, adult, pool1	10042-101F6	11.83	5.42	1.77	0.44	0.11
cruciate ligament, donor2	10295-104G7	43.77	6.48	1.62	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	29.69	16.85	3.21	0.00	0.00
diencephalon, adult	10193-103E4	31.92	12.00	4.80	2.16	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	105.39	49.60	30.31	5.97	5.05
ductal cell carcinoma cell line:KLM-1	10438-106E6	21.28	22.31	9.74	1.80	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	32.98	9.39	13.00	5.06	2.89
ductus deferens, adult	10196-103E7	26.91	7.97	2.49	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	53.29	25.92	5.76	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	72.09	11.77	2.21	0.00	1.47
dura mater, adult, donor1	10041-101F5	24.69	7.60	4.46	0.50	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	11.99	26.43	39.53	9.55	1.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	24.65	36.25	42.56	21.64	2.72
embryonic pancreas cell line:1B2C6	10604-108F1	17.88	19.73	5.55	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	27.85	12.41	7.27	1.51	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	18.22	17.91	5.56	1.23	0.93
embryonic pancreas cell line:2C6	10603-108E9	34.15	10.51	5.25	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	22.12	23.46	37.88	3.35	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	29.18	14.14	15.77	2.90	1.99
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	33.29	49.53	27.02	3.38	1.29
epidermoid carcinoma cell line:A431	10426-106D3	24.23	22.57	9.45	6.11	2.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	13.75	13.64	5.94	2.86	1.54
epididymis, adult	10197-103E8	29.72	10.26	2.30	0.42	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	14.02	8.16	2.31	1.24	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	30.28	11.80	13.37	5.51	4.33
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	26.87	19.79	17.17	7.86	2.75
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	24.01	13.68	12.60	6.99	1.87
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	20.50	20.28	15.91	7.39	3.25
esophagus, adult, pool1	10015-101C6	26.76	11.79	3.93	0.74	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	40.70	18.91	9.64	1.13	1.50
eye - muscle inferior rectus, donor1	10272-104E2	21.73	9.66	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	8.93	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	36.69	11.46	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	36.43	2.91	8.74	1.46	0.00
eye, fetal, donor1	10054-101G9	46.02	11.19	1.78	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	61.55	40.65	29.62	9.75	2.44
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	36.33	25.17	26.12	13.06	2.85
frontal lobe, adult, pool1	10040-101F4	12.20	13.98	0.47	0.84	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	24.02	36.63	7.51	2.40	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	15.82	16.64	6.13	4.30	1.19
gall bladder, adult	10198-103E9	23.18	9.42	4.59	0.24	0.97
gamma delta positive T cells, donor1	11937-126A2	174.48	14.50	2.68	1.07	2.68
gamma delta positive T cells, donor2	11938-126A3	110.55	14.94	4.48	0.75	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	37.60	19.43	15.84	4.01	1.69
gastric adenocarcinoma cell line:MKN45	10612-108F9	118.76	21.28	3.87	1.55	2.90
gastric cancer cell line:AZ521	10549-107H9	48.04	33.77	37.05	3.93	3.77
gastric cancer cell line:GSS	10560-108A2	48.51	21.97	25.63	2.75	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	32.44	18.51	23.53	2.97	1.14
giant cell carcinoma cell line:LU65	10487-107B1	31.32	50.83	16.64	11.36	7.00
giant cell carcinoma cell line:Lu99B	10433-106E1	37.37	10.36	2.10	7.56	2.80
glassy cell carcinoma cell line:HOKUG	10688-109F4	18.46	16.21	8.73	1.50	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	9.39	11.29	7.71	1.90	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	16.57	11.94	8.43	2.11	0.14
glioblastoma cell line:T98G	10485-107A8	21.19	18.43	11.26	2.76	0.99
glioma cell line:GI-1	10413-106B8	19.33	8.49	9.37	1.46	0.88
globus pallidus - adult, donor10196	10175-103C4	53.21	12.39	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	15.13	7.81	2.44	0.49	0.00
globus pallidus, adult, donor10258	10367-105F7	31.49	8.22	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	22.38	21.32	6.40	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	9.79	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	162.02	31.36	104.53	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	27.84	19.20	6.72	0.32	2.56
hIPS +CCl2, biol_rep1	14383-156B9	257.10	81.26	128.55	23.87	7.35
hIPS +CCl2, biol_rep2	14384-156C1	338.83	65.39	123.00	19.21	6.86
hIPS +CCl2, biol_rep3	14385-156C2	485.65	71.49	137.19	10.31	4.51
hIPS, biol_rep1	14380-156B6	99.17	66.12	135.11	4.31	1.44
hIPS, biol_rep2	14381-156B7	261.32	65.84	115.23	10.97	1.37
hIPS, biol_rep3	14382-156B8	130.21	32.00	19.86	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	58.04	16.09	16.38	7.76	3.16
heart - mitral valve, adult	10205-103F7	22.72	9.87	0.30	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	12.81	8.89	0.52	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	26.64	39.13	8.33	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	13.47	11.84	5.71	0.41	0.82
heart, adult, diseased, donor1	10051-101G6	5.54	6.39	0.00	0.00	0.85
heart, adult, pool1	10016-101C7	11.50	11.73	0.69	0.00	0.69
heart, fetal, pool1	10046-101G1	22.28	16.84	3.70	0.21	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	37.64	21.29	4.63	0.31	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	45.19	7.14	8.32	4.76	5.95
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	29.61	47.51	32.93	9.28	2.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	28.16	53.53	36.17	9.83	4.25
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	26.58	46.08	35.37	8.89	3.64
hepatoma cell line:Li-7	10484-107A7	14.24	15.90	8.12	1.11	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	80.00	36.48	35.18	9.45	3.72
hippocampus - adult, donor10196	10169-103B7	26.50	21.77	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	13.27	12.65	0.82	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	79.17	13.44	1.99	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	9.87	16.57	4.23	2.47	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	188.60	183.71	311.89	59.81	14.04
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	56.55	85.61	121.54	22.78	5.89
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	72.11	99.53	134.82	26.41	7.62
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	79.50	23.12	26.50	3.38	4.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	90.37	34.08	28.92	3.36	3.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	71.75	44.41	32.65	5.31	2.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	56.35	22.48	24.23	2.04	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	44.59	18.96	23.05	1.72	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	40.87	21.69	20.44	1.67	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	64.17	39.54	39.31	4.03	2.60
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	48.38	36.32	33.43	3.21	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	64.64	45.78	39.05	3.37	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	43.82	68.70	121.74	18.93	5.01
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	138.05	98.75	163.60	28.99	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	107.35	154.48	428.52	51.49	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	55.75	28.64	24.63	3.05	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	82.85	20.50	18.75	1.74	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	125.94	46.48	45.98	4.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	42.76	17.90	12.25	0.94	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	89.12	23.19	10.46	1.82	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	59.83	30.07	11.28	2.51	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	43.60	40.17	16.00	3.27	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	72.87	31.64	17.13	4.06	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	49.02	27.20	20.03	1.79	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	50.99	89.42	133.57	17.37	7.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	86.44	75.03	108.41	15.41	5.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	104.53	154.34	242.95	37.56	5.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	106.33	43.66	35.21	2.82	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	59.23	30.41	30.41	2.22	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	45.09	39.95	36.01	5.75	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	65.16	17.58	12.93	2.59	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	77.71	19.26	11.29	0.00	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	36.17	21.29	20.01	1.03	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	70.05	34.26	30.17	2.30	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	76.48	27.26	21.20	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	45.37	45.70	34.61	4.70	2.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	77.52	85.25	111.82	20.29	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	94.03	122.11	232.63	36.10	13.82
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	73.17	89.27	139.03	17.56	4.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	67.24	24.45	21.70	2.14	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	478.23	159.41	234.23	19.52	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	92.66	48.65	58.58	9.60	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	79.36	20.80	15.87	4.38	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	59.35	22.07	12.67	1.81	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	53.38	16.37	15.30	2.49	2.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	51.32	23.87	25.06	3.58	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	52.41	28.57	18.01	2.71	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	49.03	31.52	23.71	3.23	2.42
immature langerhans cells, donor1	11904-125F5	80.39	6.54	8.48	0.97	0.48
immature langerhans cells, donor2	11905-125F6	68.92	7.92	5.54	0.79	0.00
insula, adult, pool1	10039-101F3	10.32	16.09	1.51	0.28	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	97.87	34.79	26.34	3.58	2.60
kidney, adult, pool1	10017-101C8	15.92	18.22	3.10	0.40	0.40
kidney, fetal, pool1	10045-101F9	17.26	10.75	2.90	0.21	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	43.60	45.30	45.59	1.70	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	60.41	4.98	11.47	1.24	1.38
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	19.08	8.81	4.04	0.92	0.55
left atrium, adult, donor1	10079-102A7	23.97	9.81	1.63	0.00	0.00
left ventricle, adult, donor1	10078-102A6	16.69	14.66	2.02	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	75.24	32.01	21.62	9.85	3.28
leiomyoma cell line:10964C	10569-108B2	22.63	7.90	11.86	4.67	2.16
leiomyoma cell line:15242A	10570-108B3	34.24	25.00	14.13	5.43	2.17
leiomyoma cell line:15425	10571-108B4	20.64	17.73	13.60	3.89	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	44.45	44.45	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	23.00	6.27	14.64	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	89.84	46.63	42.62	4.72	2.60
liposarcoma cell line:KMLS-1	10782-110G8	40.46	19.21	12.18	0.78	0.31
liposarcoma cell line:SW 872	10726-110A6	30.95	9.63	7.19	0.61	0.85
liver, adult, pool1	10018-101C9	16.69	22.85	6.32	1.46	1.46
liver, fetal, pool1	10086-102B5	15.99	15.99	7.53	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	9.62	11.08	1.31	0.58	0.58
locus coeruleus, adult, donor10252	10165-103B3	18.27	10.70	1.29	0.37	0.55
locus coeruleus, adult, donor10258	10375-105G6	13.82	14.95	0.85	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	21.03	32.39	10.52	1.68	0.42
lung adenocarcinoma cell line:A549	10499-107C4	15.36	8.44	6.23	1.94	1.11
lung adenocarcinoma cell line:PC-14	10408-106B3	22.06	6.20	6.89	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	46.66	20.17	16.61	3.03	2.50
lung, adult, pool1	10019-101D1	22.80	8.86	1.54	0.12	0.47
lung, fetal, donor1	10068-101I5	77.06	18.84	4.28	0.00	0.57
lung, right lower lobe, adult, donor1	10075-102A3	23.83	15.12	2.29	0.00	0.46
lymph node, adult, donor1	10077-102A5	47.81	5.21	2.37	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	81.53	28.27	8.99	3.07	2.63
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	75.01	33.51	25.81	4.53	4.08
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	21.24	22.94	7.65	1.70	0.85
mature adipocyte, donor1	12231-129F8	15.98	4.00	1.33	0.00	0.44
mature adipocyte, donor2	12232-129F9	18.68	7.06	0.21	0.42	0.21
mature adipocyte, donor3	12233-129G1	15.41	3.79	0.95	0.47	0.00
mature adipocyte, donor4	12234-129G2	36.59	5.53	1.05	0.79	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	34.55	30.26	25.73	3.10	2.38
medial frontal gyrus - adult, donor10196	10170-103B8	30.46	22.56	0.00	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	10.48	11.59	0.18	0.55	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	47.34	21.29	1.59	0.95	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	43.08	43.08	12.37	5.12	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	17.55	23.96	1.35	1.18	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	16.55	12.95	0.64	0.64	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	25.04	1.93	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	28.71	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	20.46	19.38	4.31	0.72	0.72
medulla oblongata - adult, donor10196	10174-103C3	35.04	14.93	3.89	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	12.85	10.68	0.31	0.31	0.15
medulla oblongata, adult, pool1	10038-101F2	10.04	8.57	0.98	0.41	0.33
medulla oblongata, newborn, donor10223	10361-105F1	14.93	18.05	5.21	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	150.34	47.60	48.93	4.65	1.77
medulloblastoma cell line:ONS-76	10759-110E3	17.00	16.14	6.85	3.79	0.98
melanoma cell line:COLO 679	10514-107E1	20.84	34.07	14.09	4.02	2.30
melanoma cell line:G-361	10465-106H6	48.59	21.17	17.37	4.34	3.53
meningioma cell line:HKBMM	10691-109F7	30.57	21.89	11.40	1.27	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.03	22.03	33.48	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	28.51	34.74	24.37	2.85	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	47.87	34.37	24.24	7.98	4.14
mesenchymal precursor cell - adipose, donor2	11748-123G2	51.81	16.72	13.45	2.91	2.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	43.48	22.36	14.49	6.63	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	46.64	16.72	8.57	1.26	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	55.07	27.92	15.21	2.70	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	49.97	15.96	11.80	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	49.60	13.56	13.22	0.86	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	38.76	19.55	10.81	1.96	1.15
mesenchymal precursor cell - cardiac, donor3	11754-123G8	45.89	27.85	18.17	3.58	1.46
mesenchymal precursor cell - cardiac, donor4	11755-123G9	33.08	37.27	21.74	4.05	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	23.19	24.61	11.95	2.56	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	54.34	11.20	9.88	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	35.15	22.83	13.84	3.18	1.52
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	34.21	20.60	6.63	3.84	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	49.82	22.66	5.51	3.47	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	32.35	7.55	5.75	1.08	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.62	16.14	3.41	0.52	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	23.03	13.45	9.58	2.74	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	31.47	38.60	33.56	9.65	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	33.47	21.22	12.10	2.69	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	38.25	17.59	11.64	1.49	1.40
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	56.33	9.94	3.31	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	32.05	10.59	6.01	2.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.42	38.73	16.00	7.58	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	56.17	15.98	17.81	2.28	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	50.39	15.86	14.84	1.53	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	45.81	15.44	12.83	1.05	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	34.81	10.78	9.24	2.16	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	43.54	17.89	13.65	3.06	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	43.32	15.91	11.17	2.37	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	38.51	16.50	13.36	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	27.34	12.05	10.19	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	58.26	22.50	14.42	0.29	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	50.64	14.28	9.59	1.78	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	36.53	12.02	11.54	2.88	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	48.40	13.93	16.87	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	40.28	14.43	11.41	1.01	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	47.49	15.15	15.56	2.46	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	41.67	11.60	12.46	1.72	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	54.69	30.08	24.61	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	123.96	30.99	20.66	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	66.26	22.41	12.67	3.25	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	66.93	17.46	13.09	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	92.76	20.26	13.86	3.73	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	62.97	22.90	16.36	3.27	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	59.09	16.33	15.94	1.55	2.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	48.27	27.28	18.89	0.00	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	61.59	8.94	11.92	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	71.51	19.07	33.37	9.53	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	69.38	11.27	12.45	2.37	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	80.42	18.28	23.15	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	91.21	19.00	14.57	1.90	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	67.26	21.04	16.90	1.72	2.41
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	64.48	12.90	19.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	67.86	11.98	15.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	110.20	10.33	17.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	75.38	20.78	18.74	0.41	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	95.33	30.19	26.22	1.59	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	89.02	25.35	14.74	0.59	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	65.15	18.39	21.20	0.94	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	93.57	14.70	20.05	2.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	101.71	27.20	15.37	3.55	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	105.29	41.09	5.14	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	86.05	24.09	9.64	1.38	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	53.44	25.24	4.95	1.98	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	57.20	13.46	2.24	2.24	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	68.06	22.90	5.09	4.45	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	30.63	21.76	3.22	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	67.60	17.44	4.36	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	44.35	16.47	2.53	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	37.02	9.10	4.25	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	54.23	22.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	60.13	16.47	1.65	2.47	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	76.99	23.81	8.93	1.98	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	66.85	12.01	5.84	1.95	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	55.01	14.26	7.13	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	18.57	10.06	9.28	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	18.90	17.72	5.43	3.54	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	27.57	31.74	18.30	1.62	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	17.09	8.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	14.18	33.29	26.61	3.49	1.44
mesothelioma cell line:Mero-25	10850-111F4	22.47	26.55	6.81	3.40	0.45
mesothelioma cell line:Mero-41	10851-111F5	25.43	9.78	6.60	1.47	0.00
mesothelioma cell line:Mero-48a	10852-111F6	28.12	29.89	23.47	2.21	1.11
mesothelioma cell line:Mero-82	10853-111F7	41.00	30.75	27.59	2.89	1.58
mesothelioma cell line:Mero-83	10854-111F8	31.66	18.72	17.53	4.26	1.53
mesothelioma cell line:Mero-84	10855-111F9	19.97	18.71	8.85	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	43.06	29.61	13.04	2.07	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	31.14	21.87	9.77	4.97	2.82
mesothelioma cell line:NCI-H226	10846-111E9	38.01	39.28	47.06	6.52	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	20.67	13.15	8.37	3.25	0.51
mesothelioma cell line:NCI-H28	10845-111E8	27.23	12.21	8.65	2.29	1.27
mesothelioma cell line:No36	10857-111G2	27.73	11.09	12.07	2.61	0.00
mesothelioma cell line:ONE58	10858-111G3	24.66	15.99	7.86	1.90	0.00
migratory langerhans cells, donor1	11901-125F2	32.05	5.95	2.69	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	13.92	4.03	0.24	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	67.66	8.44	4.13	0.36	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	9.47	29.38	4.24	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	29.67	42.60	42.81	3.18	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	39.85	20.73	12.21	2.76	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	62.99	5.52	11.61	2.66	2.28
myelodysplastic syndrome cell line:SKM-1	10772-110F7	81.31	39.36	28.46	6.10	4.80
myeloma cell line:PCM6	10474-106I6	48.23	15.42	16.21	0.99	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	17.76	7.10	9.64	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	29.62	11.18	2.35	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	35.99	18.94	7.47	2.45	1.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	31.03	24.42	9.05	4.85	2.72
nasal epithelial cells, donor2	12227-129F4	67.34	13.25	6.62	2.21	0.55
neuroblastoma cell line:CHP-134	10508-107D4	109.51	42.33	54.52	2.07	1.84
neuroblastoma cell line:NB-1	10539-107G8	47.89	49.20	25.63	4.49	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	64.95	38.38	55.89	1.48	0.42
neuroblastoma cell line:NH-12	10555-107I6	154.11	29.07	32.98	1.86	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	63.10	9.73	23.72	0.71	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	55.12	17.42	7.92	2.22	1.74
neuroectodermal tumor cell line:TASK1	10774-110F9	115.32	27.17	17.31	2.42	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	73.11	15.26	12.72	6.99	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	31.94	27.15	12.78	1.86	0.80
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	82.02	27.90	9.98	0.85	2.54
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	16.01	37.62	26.42	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	67.65	34.30	17.63	3.53	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	21.55	17.34	11.30	0.53	0.79
nucleus accumbens, adult, pool1	10037-101F1	13.12	13.31	1.22	0.84	0.28
occipital cortex - adult, donor10196	10172-103C1	32.97	26.78	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	12.34	13.69	0.27	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	12.01	16.01	4.73	1.09	0.00
occipital lobe, adult, donor1	10076-102A4	14.96	16.27	0.79	0.79	0.52
occipital lobe, fetal, donor1	10073-102A1	59.22	21.03	5.15	1.72	0.00
occipital pole, adult, pool1	10036-101E9	5.52	8.36	0.39	0.08	0.08
olfactory region, adult	10195-103E6	19.30	9.36	0.57	1.53	0.38
optic nerve, donor1	10277-104E7	32.02	2.00	2.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	19.48	14.92	21.64	1.03	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	33.80	19.23	4.53	8.11	3.85
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	19.81	14.56	15.24	1.86	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	51.40	19.52	15.94	2.43	1.39
osteoclastoma cell line:Hs 706.T	10704-109H2	20.87	10.58	4.70	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	60.73	55.13	29.90	7.47	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	46.02	18.24	21.21	4.88	3.61
ovary, adult, pool1	10020-101D2	28.91	8.39	4.37	0.70	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	28.41	20.17	14.12	2.38	1.10
pancreas, adult, donor1	10049-101G4	123.22	41.39	15.05	0.00	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	45.28	24.04	22.92	2.80	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	21.29	14.65	8.52	2.73	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	25.50	10.10	8.61	0.00	0.50
paracentral gyrus, adult, pool1	10035-101E8	10.34	11.35	0.73	1.10	0.27
parietal cortex, adult, donor10258	10373-105G4	55.78	12.48	4.40	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	28.21	15.99	0.00	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	13.97	13.68	1.71	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	11.72	12.60	0.44	0.53	0.00
parietal lobe, fetal, donor1	10072-101I9	62.07	25.22	11.64	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	18.32	17.57	1.87	0.37	0.37
parotid gland, adult	10199-103F1	51.18	8.02	4.32	0.62	1.23
penis, adult	10200-103F2	30.62	7.52	1.61	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	33.28	23.99	8.37	1.12	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	28.56	16.90	3.50	0.87	0.58
pineal gland - adult, donor10196	10179-103C8	12.90	14.19	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	17.77	24.28	0.59	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	18.81	20.07	0.63	1.25	1.88
pituitary gland - adult, donor10196	10180-103C9	104.22	34.40	5.06	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	46.38	38.05	1.56	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	57.88	28.09	2.55	0.85	1.70
placenta, adult, pool1	10021-101D3	16.88	15.27	4.30	0.22	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	65.29	18.41	14.57	11.79	4.77
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	21.48	7.94	3.58	0.78	0.93
pons, adult, pool1	10033-101E6	9.12	10.76	0.95	0.43	0.09
postcentral gyrus, adult, pool1	10032-101E5	9.33	12.29	1.13	0.61	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	10.46	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	99.14	11.02	60.59	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	199.51	0.00	46.94	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	24.18	18.94	8.74	9.03	2.04
prostate cancer cell line:PC-3	10439-106E7	16.88	21.05	5.81	1.45	0.36
prostate, adult, pool1	10022-101D4	33.83	9.79	3.99	0.00	0.36
putamen, adult, donor10196	10176-103C5	12.75	18.18	0.94	1.18	0.47
putamen, adult, donor10252	10152-102I8	41.18	13.73	3.92	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	81.96	43.71	56.83	7.65	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	32.13	14.98	0.72	0.48	0.24
putamen, newborn, donor10223	10365-105F5	41.23	36.73	11.99	3.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	30.55	9.31	8.44	2.04	2.91
rectum, fetal, donor1	10067-101I4	34.77	8.35	6.95	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	12.72	5.94	2.33	2.12	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	33.55	18.23	2.07	4.14	1.66
retina, adult, pool1	10030-101E3	17.30	7.45	0.89	0.20	0.30
retinoblastoma cell line:Y79	10475-106I7	84.96	51.18	40.27	5.20	5.20
rhabdomyosarcoma cell line:KYM-1	10787-110H4	65.90	112.99	220.45	19.30	4.92
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	55.12	39.93	35.15	1.97	2.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	36.38	10.61	5.30	0.00	4.55
salivary acinar cells, donor1	11771-123I7	63.29	19.58	13.60	1.94	1.13
salivary acinar cells, donor2	11772-123I8	75.45	12.53	11.43	0.69	0.96
salivary acinar cells, donor3	11773-123I9	64.88	11.25	5.30	0.00	0.00
salivary gland, adult, pool1	10093-102C3	91.51	11.44	2.29	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	12.06	6.32	3.63	1.10	1.26
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	15.87	8.82	4.70	1.41	2.23
seminal vesicle, adult	10201-103F3	28.04	9.52	2.12	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	23.08	25.26	18.22	1.70	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	42.78	4.28	1.01	1.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	25.09	13.05	7.02	5.02	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	19.88	7.25	14.64	0.81	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	18.24	14.48	8.29	1.88	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	36.77	23.10	22.58	3.35	4.26
skeletal muscle - soleus muscle, donor1	10282-104F3	29.79	19.15	2.84	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	27.47	21.23	2.64	0.60	0.48
skeletal muscle, fetal, donor1	10066-101I3	46.23	7.04	6.03	0.00	0.00
skin, adult, donor1	10074-102A2	61.07	13.57	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	53.02	19.57	5.05	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	49.36	76.04	24.68	0.67	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	56.74	28.37	19.86	0.63	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	62.84	17.54	4.63	6.17	4.05
small cell lung carcinoma cell line:LK-2	10541-107H1	40.88	20.11	20.11	3.30	2.64
small cell lung carcinoma cell line:NCI-H82	10842-111E5	57.91	19.78	7.24	9.17	2.73
small cell lung carcinoma cell line:WA-hT	10562-108A4	32.91	22.45	21.79	0.87	0.65
small intestine, adult, pool1	10024-101D6	22.69	11.71	1.91	0.72	0.96
small intestine, fetal, donor1	10064-101I1	46.68	14.74	6.14	0.49	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	22.05	6.67	7.69	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	37.22	8.27	2.07	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	38.06	21.98	7.24	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	17.66	9.18	0.69	0.92	0.92
spinal cord, adult, donor10252	10159-103A6	26.02	13.80	1.18	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	341.06	21.45	2.77	0.69	1.38
spinal cord, fetal, donor1	10056-101H2	30.49	14.64	1.22	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	25.72	18.83	6.89	0.46	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	28.68	17.62	8.81	1.34	0.45
spleen, adult, pool1	10025-101D7	26.21	10.79	3.85	0.44	0.77
spleen, fetal, pool1	10044-101F8	17.56	8.58	1.51	0.24	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	29.29	12.94	16.04	2.38	2.59
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	22.03	12.15	11.58	0.95	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	19.57	13.98	9.78	0.70	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	43.00	25.02	15.64	3.13	3.13
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	18.23	27.35	5.52	2.93	1.58
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	29.23	22.45	13.56	4.66	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	16.50	12.69	13.12	0.42	0.42
stomach, fetal, donor1	10062-101H8	57.67	10.68	5.34	2.14	1.07
submaxillary gland, adult	10202-103F4	45.00	6.84	1.71	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	19.73	10.59	1.25	0.00	0.42
substantia nigra, adult, donor10258	10371-105G2	117.93	13.97	3.10	1.03	0.52
substantia nigra, newborn, donor10223	10358-105E7	22.61	15.54	4.24	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	35.77	26.14	29.58	7.80	2.98
temporal lobe, adult, pool1	10031-101E4	6.36	10.34	0.76	0.34	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	72.65	27.07	9.26	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	92.30	24.61	11.87	2.20	1.32
tenocyte, donor1	11763-123H8	37.70	16.06	10.47	0.70	0.35
tenocyte, donor2	11765-123I1	48.07	14.12	3.82	0.38	1.14
tenocyte, donor3	11768-123I4	48.56	22.98	11.12	1.11	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	44.02	40.79	49.80	5.95	1.87
teratocarcinoma cell line:NCR-G1	10798-110I6	64.43	40.23	19.58	6.01	3.39
teratocarcinoma cell line:PA-1	10807-111A6	72.99	59.36	39.05	5.58	2.63
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	46.21	41.51	54.71	7.11	3.05
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	57.48	55.21	50.30	2.27	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	48.86	34.25	25.41	4.36	2.94
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	32.24	134.19	58.30	5.86	2.28
testis, adult, pool1	10026-101D8	18.68	11.70	3.11	1.61	1.07
testis, adult, pool2	10096-102C6	25.26	11.73	1.80	2.71	0.90
thalamus - adult, donor10196	10168-103B6	57.41	29.81	15.46	2.21	0.00
thalamus, adult, donor10252	10154-103A1	15.32	7.97	1.25	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	32.33	10.78	6.16	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.05	12.52	2.47	1.15	0.16
thalamus, newborn, donor10223	10366-105F6	20.71	58.68	33.94	12.66	1.15
throat, adult	10209-103G2	27.96	9.49	3.50	1.00	0.75
throat, fetal, donor1	10061-101H7	45.10	16.45	6.40	1.52	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	52.27	44.91	56.04	5.56	2.58
thymus, adult, pool1	10027-101D9	22.07	11.13	6.86	1.09	1.09
thymus, fetal, pool1	10043-101F7	32.11	14.86	5.40	0.83	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	27.92	27.52	24.46	4.12	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	75.29	14.95	11.45	6.84	5.87
thyroid, adult, pool1	10028-101E1	38.63	15.12	4.39	0.47	0.47
thyroid, fetal, donor1	10060-101H6	25.05	13.97	1.05	0.53	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	12.32	0.00	3.08	0.00	3.08
tongue, adult	10203-103F5	34.42	12.33	11.40	3.02	0.70
tongue, fetal, donor1	10059-101H5	44.53	25.22	3.55	0.79	0.39
tonsil, adult, pool1	10047-101G2	27.65	10.62	5.01	0.80	0.50
trachea, adult, pool1	10029-101E2	23.64	13.01	6.22	0.82	0.41
trachea, fetal, donor1	10058-101H4	56.55	11.54	7.69	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	31.18	23.74	13.82	2.48	2.83
transitional-cell carcinoma cell line:5637	10418-106C4	18.84	19.55	15.70	1.72	0.91
transitional-cell carcinoma cell line:JMSU1	10492-107B6	52.96	28.52	19.27	3.92	2.98
tridermal teratoma cell line:HGRT	10694-109G1	34.25	15.22	15.22	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	64.00	12.27	9.14	1.69	1.44
umbilical cord, fetal, donor1	10057-101H3	35.47	10.43	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	70.98	9.90	5.12	0.85	0.34
uterus, fetal, donor1	10055-101H1	68.09	13.31	10.24	1.02	0.51
vagina, adult	10204-103F6	45.23	10.34	1.94	0.00	0.00
vein, adult	10191-103E2	36.83	8.99	1.75	1.53	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	120.70	11.75	13.08	3.74	2.40